日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Persistent Classical and Atypical Memory B Cells Underlie Heterogeneous Vaccine Responses in Ocrelizumab-Treated Multiple Sclerosis.

持续存在的经典和非典型记忆 B 细胞是奥克瑞珠单抗治疗的多发性硬化症中疫苗反应异质性的基础。

期刊:
影响因子:
doi:10.1101/2025.11.03.686372
Curtin Ryan, Velmurugu Yogambigai, Dibba Fatoumatta, Hao Yuan, Sreenivasaiah Chaitra, Khodadadi-Jamayran Alireza, Nyovanie Samantha, Kim Angie, Samanovic Marie L, Mulligan Mark, Priest Jessica, Cabatingan Mark, Winger Ryan C, Patskovsky Yury, Kister Ilya, Silverman Gregg J, Krogsgaard Michelle
神经科学
细胞生物学
T细胞
多发性硬化症
发表日期：2025
文献求助 收藏

Longitudinal study of immunity to SARS-CoV2 in ocrelizumab-treated MS patients up to 2 years after COVID-19 vaccination

一项关于接受奥瑞珠单抗治疗的多发性硬化症患者在接种新冠疫苗后长达两年内对SARS-CoV-2免疫力的纵向研究

期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.52081
Kister, Ilya; Curtin, Ryan; Piquet, Amanda L; Borko, Tyler; Pei, Jinglan; Banbury, Barbara L; Bacon, Tamar E; Kim, Angie; Tuen, Michael; Velmurugu, Yogambigai; Nyovanie, Samantha; Selva, Sean; Samanovic, Marie I; Mulligan, Mark J; Patskovsky, Yury; Priest, Jessica; Cabatingan, Mark; Winger, Ryan C; Krogsgaard, Michelle; Silverman, Gregg J
SARS-CoV-2
新冠
神经科学
多发性硬化症
微生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Cellular and Humoral Immunity to SARS-CoV-2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease-Modifying Therapies: A Multi-Ethnic Observational Study.

接受奥瑞珠单抗和其他疾病修饰疗法治疗的多发性硬化症患者的 SARS-CoV-2 感染的细胞和体液免疫：一项多民族观察性研究

期刊:Annals of Neurology
影响因子:7.7
doi:10.1002/ana.26346
Kister Ilya, Patskovsky Yury, Curtin Ryan, Pei Jinglan, Perdomo Katherine, Rimler Zoe, Voloshyna Iryna, Samanovic Marie I, Cornelius Amber R, Velmurugu Yogambigai, Nyovanie Samantha, Kim Joseph J, Tardio Ethan, Bacon Tamar E, Zhovtis Ryerson Lana, Raut Pranil, Pedotti Rosetta, Hawker Kathleen, Raposo Catarina, Priest Jessica, Cabatingan Mark, Winger Ryan C, Mulligan Mark J, Krogsgaard Michelle, Silverman Gregg J
细胞生物学
多发性硬化症
发表日期：2022
文献求助 收藏

Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies.

接受不同疾病修饰疗法的 MS 患者对 SARS-CoV-2 的混合免疫和疫苗诱导免疫

期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.51664
Kister Ilya, Curtin Ryan, Pei Jinglan, Perdomo Katherine, Bacon Tamar E, Voloshyna Iryna, Kim Joseph, Tardio Ethan, Velmurugu Yogambigai, Nyovanie Samantha, Valeria Calderon Andrea, Dibba Fatoumatta, Stanzin Igda, Samanovic Marie I, Raut Pranil, Raposo Catarina, Priest Jessica, Cabatingan Mark, Winger Ryan C, Mulligan Mark J, Patskovsky Yury, Silverman Gregg J, Krogsgaard Michelle
炎症/感染
新冠
发表日期：2022
文献求助 收藏

Site-directed mutagenesis of large DNA palindromes: construction and in vitro characterization of herpes simplex virus type 1 mutants containing point mutations that eliminate the oriL or oriS initiation function

大型DNA回文序列的定点诱变：构建和体外表征含有消除oriL或oriS起始功能的点突变的1型单纯疱疹病毒突变体

期刊:Journal of Virology
影响因子:3.8
doi:10.1128/JVI.79.20.12783-12797.2005
Balliet, John W; Min, Jonathan C; Cabatingan, Mark S; Schaffer, Priscilla A
微生物学
疱疹
发表日期：2005
文献求助 收藏

Induction of herpes simplex virus type 1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells after growth arrest-release

生长停滞-释放后，Vero 和 NB41A3 细胞中表达的细胞活性可诱导 1 型单纯疱疹病毒即刻早期基因的表达。

期刊:Journal of Virology
影响因子:3.8
doi:10.1128/JVI.68.11.6871-6882.1994
Ralph, W M Jr; Cabatingan, M S; Schaffer, P A
微生物学
细胞生物学
疱疹
发表日期：1994
文献求助 收藏